Leigh Syndrome, also known as Mitochondrial Encephalopathy, is a severe neurological disorder that typically arises in the first year of life. This condition is characterized by progressive loss of mental and movement abilities, which can lead to severe neurological and physical impairment. Leigh Syndrome is caused by genetic mutations affecting the mitochondria, the energy-producing structures within cells, leading to energy production failure and, subsequently, cell death, particularly in the brain, muscles, and heart.
To diagnose this complex condition, a Mitochondrial Encephalopathy Gene Panel Test is utilized. This comprehensive genetic test screens for mutations in multiple genes known to be associated with Leigh Syndrome and other mitochondrial disorders. By examining a broad panel of genes, this test provides a more accurate diagnosis, guiding treatment options and management strategies for affected individuals.
The test is available at DNA Labs UAE, a leading facility in genetic testing and diagnostics. The cost of the Mitochondrial Encephalopathy Gene Panel Test is 7200 AED. Conducting the test in a specialized and reputable laboratory like DNA Labs UAE ensures high accuracy and reliability of the results, which is crucial for the effective management of Leigh Syndrome and related mitochondrial disorders. This test is a critical step in the journey towards understanding and managing these complex conditions, offering hope for affected families through precise diagnosis and the potential for targeted therapies.
The Lung Cancer Panel 5 EGFRKRASBRAFALK1ROS1 Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to identify genetic mutations in lung cancer patients. This panel tests for alterations in five critical genes: EGFR, KRAS, BRAF, ALK1, and ROS1, which are known to play significant roles in the development and progression of lung cancer. By detecting mutations in these genes, the test can help guide personalized treatment plans, including targeted therapies that may improve patient outcomes. The cost of the test is 7200 AED, making it a valuable investment for those seeking advanced, personalized cancer care. Through its precise identification of genetic mutations, the Lung Cancer Panel 5 provides crucial insights that can lead to more effective and tailored treatment strategies for individuals battling lung cancer.
The "Lung Cancer Panel 7 EGFRBRAFALK1ROS1 MET Test" is a comprehensive genomic test offered by DNA Labs UAE, designed to identify genetic mutations in lung cancer patients. This panel specifically targets mutations in seven critical genes: EGFR, BRAF, ALK, ROS1, and MET, which are known to influence the growth and spread of lung cancer cells. By detecting these mutations, the test provides essential information that can guide personalized treatment plans, including targeted therapies that may offer better outcomes for patients.
The cost of the test is 7200 AED. Conducted in the advanced facilities of DNA Labs UAE, this test represents a significant step forward in the precision medicine approach to treating lung cancer, allowing for more tailored and effective treatment strategies based on the genetic profile of an individual's cancer.
The Lysosomal Storage Disorder (LSD) Gene Panel Test is a comprehensive genetic screening designed to identify mutations in genes associated with lysosomal storage disorders, a group of rare inherited metabolic conditions. This panel test is crucial for the early diagnosis and management of these disorders, enabling healthcare providers to tailor treatment plans effectively. By analyzing a wide range of genes linked to various forms of LSDs, the test offers a detailed insight into the genetic underpinnings of these conditions, which can include Gaucher disease, Fabry disease, Pompe disease, and many others.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures high accuracy and reliability in results, thanks to their state-of-the-art technology and expert team. The cost of the Lysosomal Storage Disorder Gene Panel Test is set at 7200 AED, reflecting the comprehensive nature of the analysis and the significant value it provides in guiding patient care and genetic counseling. This test is a vital tool for individuals with a family history of lysosomal storage disorders or presenting symptoms suggestive of these conditions, offering a path towards a clearer understanding of their health and proactive management options.
The Metabolic Disorder Gene Panel Test, available at DNA Labs UAE, is a comprehensive diagnostic tool designed to identify genetic mutations associated with a wide range of metabolic disorders. Priced at 7200 AED, this advanced genetic test offers a deep insight into the genetic factors that may contribute to metabolic issues, allowing for precise diagnosis, informed treatment decisions, and personalized management plans. By examining specific genes known to affect metabolism, the test can uncover genetic predispositions to conditions such as lipid metabolism disorders, mitochondrial disorders, and various inborn errors of metabolism. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test is a crucial step towards proactive health management and tailored healthcare, providing individuals and families with critical information to address metabolic disorders effectively.
The Microcephaly Gene Panel Test is a specialized genetic test designed to identify mutations in genes associated with microcephaly, a condition characterized by a smaller head size than that typical for an infant's age and sex. This condition can result from a variety of genetic factors and can lead to developmental delays and neurological problems. Conducted at DNA Labs UAE, a leading facility in genetic testing, the test involves analyzing the patient's DNA to pinpoint specific genetic mutations linked to microcephaly. The comprehensive nature of this panel test makes it a crucial tool for diagnosing the condition accurately, thereby facilitating appropriate medical and developmental interventions. The cost of the Microcephaly Gene Panel Test at DNA Labs UAE is 7200 AED, reflecting the intricate technology and expertise required to perform this advanced genetic analysis.
The Muscular Dystrophy Gene Panel Test is a comprehensive genetic analysis designed to identify mutations across various genes associated with muscular dystrophy, a group of genetic disorders characterized by progressive muscle weakness and degeneration. This test is crucial for diagnosing specific types of muscular dystrophy, enabling healthcare providers to tailor treatment and management plans to the individual needs of their patients. Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers a thorough examination of the genetic markers linked to muscular dystrophy. The cost of the test is 7200 AED, reflecting the advanced technology and expertise required to perform this detailed genetic analysis. By opting for this test, individuals and families affected by muscular dystrophy can gain valuable insights into their condition, facilitating informed decisions about care and potentially accessing targeted therapies.
The Nervous System Cancer Gene Panel Test is a sophisticated diagnostic tool designed to identify genetic mutations associated with cancers of the nervous system. Conducted at DNA Labs UAE, this test screens for a comprehensive range of genetic markers that are known to influence the risk, development, and progression of nervous system cancers, including brain tumors. By analyzing a patient's DNA sample, usually obtained through a simple blood draw or biopsy, the test aims to provide critical insights into the genetic underpinnings of an individual's cancer, guiding personalized treatment strategies and management plans.
The cost of the Nervous System Cancer Gene Panel Test at DNA Labs UAE is 7200 AED. This investment covers the extensive analysis required to detect and interpret the specific genetic alterations that could impact a patient's cancer treatment and prognosis. The results from this test can help healthcare providers make informed decisions about targeted therapies, surveillance strategies, and potential participation in clinical trials, ultimately aiming to improve patient outcomes in the challenging landscape of nervous system cancers.
The Neuronal Ceroid Lipofuscinosis (NCL) Gene Panel Test is a comprehensive genetic test designed to identify mutations in genes associated with Neuronal Ceroid Lipofuscinosis, a group of progressive neurodegenerative disorders primarily affecting children. These disorders are characterized by the accumulation of lipofuscin, a fatty substance, in the body's tissues, leading to symptoms such as vision loss, motor decline, and seizures. The test analyzes multiple genes known to be linked to various forms of NCL, providing crucial information for accurate diagnosis and guiding treatment options.
Offered at DNA Labs UAE, this advanced genetic test is priced at 7200 AED. The facility utilizes cutting-edge technology and adheres to strict quality standards to ensure the reliability and accuracy of the test results. By opting for the NCL Gene Panel Test at DNA Labs UAE, patients and their families can gain valuable insights into the specific genetic mutations causing the disorder, facilitating early intervention and personalized care plans to manage the condition more effectively.
The Polycystic Kidney Disease Gene Panel Test is a sophisticated genetic screening designed to identify mutations in the genes associated with Polycystic Kidney Disease (PKD), a genetic disorder characterized by the growth of numerous cysts in the kidneys. This condition can lead to various health issues, including high blood pressure, kidney failure, and cysts in other organs. Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, this test provides a comprehensive analysis of the genes known to be linked to both the Autosomal Dominant Polycystic Kidney Disease (ADPKD) and Autosomal Recessive Polycystic Kidney Disease (ARPKD), the two main types of PKD.
The test, priced at 7200 AED, involves collecting a DNA sample, typically through a blood draw, and examining it for specific genetic mutations. This detailed analysis helps in confirming a diagnosis of PKD, understanding the risk of developing the disease, and aiding in the decision-making process for family planning. Given the hereditary nature of PKD, the test is particularly recommended for individuals with a family history of the disease or those exhibiting symptoms related to PKD. Conducting the test at DNA Labs UAE ensures accuracy and reliability, backed by a team of genetic experts and state-of-the-art technology.
